E-Mail
The West Virginia Clinical and Translational Science Institute (WVCTSI) will host a special virtual event titled HIV in Rural America on March 18. During this event, researchers, state, and national health experts will discuss research presented in The Lancet s recent issue: HIV in the United States.
The event will kick off at 11:30 a.m. with brief research presentations from authors published in The Lancet issue with Sally Hodder, MD, WVCTSI director and associate vice president for clinical and translational research at WVU moderating. Presenters and topics include:
Patrick Sullivan, DVM, PhD (Emory University). Epidemiology of HIV in the USA: Epidemic Burden, Inequities, Context, and Responses
E-Mail
HSE University researchers together with specialists from the Humanitarian Action Charitable Fund (St. Petersburg) and the University of Michigan School of Public Health (USA) studied the specifics of remote work with Russian people who use drugs to reduce the harm of drug use. They discovered that the use of online platforms increases the § who use drugs to seek help. Online platforms also serve as a kind of gateway for people with problematic drug use to receive a wider range of qualified help. The authors concluded that remote work in this field should be developed and built upon in an ongoing systematic way even when the threat of coronavirus recedes. The results of the study are published in the
URL goes live when the embargo lifts
Switching from antiretroviral therapy (ART) containing tenofovir disoproxil fumarate (TDF) to ART containing tenofovir alafenamide (TAF) is associated with increased risk for significant weight increases, obesity, and rising blood lipid levels in people living with HIV. In contrast to most previous studies that were performed among treatment-naive patients, the changes in weight in the present study could not be attributed to better health due to starting HIV treatment as the patients studied were already taking ART with TDF for 6 months or longer. These findings from a cohort study are published in
Annals of Internal Medicine.
Credit: Insel Gruppe
In Switzerland about 17 000 people are living with an HIV infection, worldwide there are about 38 million. Today, the disease can be treated so successfully that a normal life can be ensured to a great extent. However, weight increases are often observed at the beginning of HIV therapy due to adaptations of the metabolism, which are part of a successful therapy. Therefore, body weight control plays an important role in HIV therapy. It is important, for example, to avoid metabolic problems that can lead to heart attacks or diabetes over the long term.
Tenofovir is the drug used as part of the standard HIV therapies. The previously, widely used TDF-based therapy (tenofovir disoproxil fumarate, TDF) has been associated with renal side effects and bone loss. It was therefore steadily replaced with a new variant, TAF-based therapy (tenofovir alafenamide), which was associated with fewer side effects. The study presented here explores evidence of excessive weight g
3 Min Read
KUALA LUMPUR (Thomson Reuters Foundation) - Political turmoil in Myanmar poses “huge risks” to the health of vulnerable people including sex workers and HIV patients, aid groups said, warning that medical supplies could be disrupted as the public healthcare system struggles to operate normally.
The Southeast Asian nation plunged into crisis after the army ousted Nobel laureate Aung San Suu Kyi’s elected government in a Feb. 1 coup, declaring a year-long state of emergency that has sparked strikes and protests - including by doctors.
Myanmar’s public hospitals and clinics, which were already under pressure due to COVID-19, are in disarray, according to medical charities, who said they were struggling to help the rising number of people turning to them for treatment.